rs143559732

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_001481.3(DRC4):​c.277G>A​(p.Val93Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000314 in 1,564,318 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 1 hom. )

Consequence

DRC4
NM_001481.3 missense

Scores

3
5
9

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 7.94

Publications

0 publications found
Variant links:
Genes affected
DRC4 (HGNC:4166): (growth arrest specific 8) This gene includes 11 exons spanning 25 kb and maps to a region of chromosome 16 that is sometimes deleted in breast and prostrate cancer. The second intron contains an apparently intronless gene, C16orf3, that is transcribed in the opposite orientation. This gene is a putative tumor suppressor gene. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
DRC4 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 33
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008260578).
BP6
Variant 16-90031485-G-A is Benign according to our data. Variant chr16-90031485-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 542270.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00143 (218/152362) while in subpopulation AFR AF = 0.00491 (204/41588). AF 95% confidence interval is 0.00435. There are 1 homozygotes in GnomAd4. There are 98 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001481.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DRC4
NM_001481.3
MANE Select
c.277G>Ap.Val93Met
missense
Exon 3 of 11NP_001472.1
DRC4
NM_001286208.2
c.-245G>A
5_prime_UTR_premature_start_codon_gain
Exon 3 of 10NP_001273137.1
DRC4
NM_001286209.2
c.202G>Ap.Val68Met
missense
Exon 3 of 11NP_001273138.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAS8
ENST00000268699.9
TSL:1 MANE Select
c.277G>Ap.Val93Met
missense
Exon 3 of 11ENSP00000268699.4
GAS8
ENST00000566266.5
TSL:1
n.*292G>A
non_coding_transcript_exon
Exon 3 of 10ENSP00000454343.1
GAS8
ENST00000566266.5
TSL:1
n.*292G>A
3_prime_UTR
Exon 3 of 10ENSP00000454343.1

Frequencies

GnomAD3 genomes
AF:
0.00143
AC:
218
AN:
152244
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00492
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000356
AC:
60
AN:
168440
AF XY:
0.000280
show subpopulations
Gnomad AFR exome
AF:
0.00537
Gnomad AMR exome
AF:
0.000157
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000829
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000213
GnomAD4 exome
AF:
0.000193
AC:
273
AN:
1411956
Hom.:
1
Cov.:
32
AF XY:
0.000165
AC XY:
115
AN XY:
697706
show subpopulations
African (AFR)
AF:
0.00694
AC:
224
AN:
32268
American (AMR)
AF:
0.000136
AC:
5
AN:
36678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25346
East Asian (EAS)
AF:
0.0000274
AC:
1
AN:
36430
South Asian (SAS)
AF:
0.0000372
AC:
3
AN:
80604
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50074
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5654
European-Non Finnish (NFE)
AF:
0.00000276
AC:
3
AN:
1086302
Other (OTH)
AF:
0.000614
AC:
36
AN:
58600
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00143
AC:
218
AN:
152362
Hom.:
1
Cov.:
32
AF XY:
0.00132
AC XY:
98
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.00491
AC:
204
AN:
41588
American (AMR)
AF:
0.000588
AC:
9
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000555
Hom.:
0
Bravo
AF:
0.00160
ESP6500AA
AF:
0.00391
AC:
17
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000344
AC:
40

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 33 Benign:2
Mar 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.15
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.033
T
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.0083
T
MetaSVM
Benign
-0.73
T
PhyloP100
7.9
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.14
Sift
Uncertain
0.0080
D
Sift4G
Uncertain
0.016
D
Polyphen
0.99
D
Vest4
0.56
MVP
0.39
MPC
0.038
ClinPred
0.10
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.30
gMVP
0.20
Mutation Taster
=58/42
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143559732; hg19: chr16-90097893; API